Skip to main content

EASD/EASL symposium: Is NAFLD a risk for health in the context of diabetes?

Receive weekly updates on the diabetes news that matters to you

Friday, September 20, 08:30–09:30. Joslin Hall, Fira Barcelona Gran Via, Spain

Chair: A. Gastaldelli, Italy

  1. Metabolic NAFLD. M. Roden, Germany
  2. Genetic NAFLD. S. Romeo, Sweden
  3. NAFL vs NASH, diagnosis and treatment: a hepatologist's perspective. E. Bugianesi, Italy

Non-alcoholic fatty liver disease (NAFLD) is increasingly common in diabetes; this symposium should help to guide clinicians to use the right approaches for diagnosis and management.

John Wilding, Professor of Medicine, UK

Back to the EASD 2019 conference hub